NEW YORK (GenomeWeb News) – Gene Logic this week named Charles Dimmler its new CEO. Dimmler replaces Mark Gessler, who will maintain his position as chairman of the board of directors.
Dimmler has been on Gene Logic’s board of directors for 10 years, and has involved in biotechnology management and finance for 20.
Affymetrix has named Robert Wayman to its board of directors.
Wayman recently retired as executive vice president and CFO at Hewlett-Packard. He had also been a director at HP, Conway, and Sybase.
Parag Saxena resigned last week as a director of Transgenomic, the company said this week. Saxena also resigned from his duties on the company’s board-compensation and audit committees.
Codon Devices has appointed Daniel Geffken to the post of chief financial officer, the company said this week.
Geffken most recently was executive vice president and CFO at Konarka Technologies
He has also served as CFO and having held positions involving fundraising, investor relations, and management at Transkaryotic Therapies, CytoTherapeutics, and Omnisonics Medical Technologies.
C. Robert Eaton has resigned from his post as president of MdBio, a non-profit group that promotes the growth of the bioscience industry in Maryland, MdBio said this week.
Julie Coons, CEO of the Tech Council of Maryland, will take Eaton’s place until a replacement is found.
Eaton, who worked for the organization for 10 years, will leave his job at the end of the month to “pursue opportunities in the private sector,” MdBio said.
The Burnham Institute for Medical Research has named Robert Zaugg vice president of business development, the institute said this week.
The La Jolla, Calif.-based non-profit operates three centers studying cancer, neurosciences, aging, infection, and inflammatory diseases.
Zaugg has worked as an executive, consultant, or scientist at companies including DermAegis, GTS Proteomics, Triton Biosciences, Vical, and Teknekron.